Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Treasury Shares (2016 - 2025)

Lisata Therapeutics' Treasury Shares history spans 11 years, with the latest figure at $708000.0 for Q4 2025.

  • For Q4 2025, Treasury Shares changed 0.0% year-over-year to $708000.0; the TTM value through Dec 2025 reached $708000.0, changed 0.0%, while the annual FY2025 figure was $708000.0, 0.0% changed from the prior year.
  • Treasury Shares reached $738.0 in Q4 2025 per LSTA's latest filing, roughly flat from $738.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $265036.0 in Q2 2025 to a low of $738.0 in Q1 2023.
  • Average Treasury Shares over 3 years is $57497.8, with a median of $738.0 recorded in 2023.
  • The largest YoY upside for Treasury Shares was 0.0% in 2024 against a maximum downside of 0.0% in 2024.
  • A 3-year view of Treasury Shares shows it stood at $708000.0 in 2023, then changed by 0.0% to $708000.0 in 2024, then changed by 0.0% to $708000.0 in 2025.
  • Per Business Quant, the three most recent readings for LSTA's Treasury Shares are $708000.0 (Q4 2025), $708000.0 (Q3 2025), and $708000.0 (Q2 2025).